Real-world safety of aliskiren in primary hypertension: A cross-database study
Fig 5
Time to onset of adverse events induced by aliskiren.
Distribution of adverse event onset time intervals (days) among study reports, presented as both the number of cases and corresponding percentage of total cases for each interval.